Research programme: HIV infections - Salus
Alternative Names: Research programme: antisense HIV infections drug therapies - Salus TherapeuticsLatest Information Update: 11 Sep 2007
At a glance
- Originator Salus Therapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 13 Nov 2000 Preclinical development for HIV infections treatment in USA (Unknown route)